
RBLX · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total Revenue | $4.89B | $3.60B | $2.80B | $2.23B | $1.92B | $923.88M | $508.39M |
| Cost of Revenue | $1.07B | $801.16M | $649.12M | $547.66M | $496.87M | $239.90M | $122.38M |
| Research & Development | $1.57B | $1.44B | $1.25B | $873.48M | $533.21M | $201.43M | $107.09M |
| Selling, General & Administrative | $580.11M | $407.51M | $390.06M | $297.32M | $303.02M | $97.34M | $41.95M |
| Operating Expenses | $6.12B | $4.67B | $4.06B | $3.15B | $2.41B | $1.19B | $584.83M |
| Operating Income | -$1.23B | -$1.06B | -$1.26B | -$923.78M | -$495.10M | -$266.14M | -$76.44M |
| Interest Expense | — | — | $40.71M | $39.90M | $7.00M | $0.00 | $0.00 |
| Income Before Taxes | -$1.07B | -$936.50M | -$1.16B | -$930.59M | -$503.80M | -$264.35M | -$71.11M |
| Provision for Income Taxes | $3.59M | $4.11M | $454.00K | $3.55M | -$320.00K | -$6.66M | $9.00K |
| Net Income | -$1.07B | -$941.00M | -$1.16B | -$934.00M | -$503.00M | -$253.25M | -$70.97M |
| Basic EPS | -$1.54 | -$1.44 | -$1.87 | -$1.55 | -$0.97 | -$1.39 | -$0.44 |
| Diluted EPS | -$1.54 | -$1.44 | -$1.87 | -$1.55 | -$0.97 | -$1.39 | -$0.44 |
| Basic Shares Outstanding | 689.61M | 647.48M | 616.45M | 595.56M | 505.86M | 182.11M | 163.05M |
| Diluted Shares Outstanding | 689.61M | 647.48M | 616.45M | 595.56M | 505.86M | 182.11M | 163.05M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | -$1.39 | -$1.55 | -$1.18 | 8 | ↑0 ↓4 |
| Dec 2027 | -$1.30 | -$1.99 | -$0.57 | 10 | ↑1 ↓4 |
| Dec 2028 | -$0.79 | -$1.49 | -$0.35 | 6 | ↑0 ↓0 |
| Dec 2029 | $0.34 | -$0.08 | $0.76 | 2 | ↑0 ↓0 |